mometasone inhaled
Selected indexed studies
- Inhaled indacaterol/glycopyrronium/mometasone furoate fixed-dose combination in moderate-to-severe asthma. (Expert Rev Respir Med, 2022) [PMID:34783265]
- Inhaled mometasone furoate: a review of its use in adults and adolescents with persistent asthma. (Drugs, 2001) [PMID:11511026]
- Mometasone or Tiotropium in Mild Asthma with a Low Sputum Eosinophil Level. (N Engl J Med, 2019) [PMID:31112384]
_Worker-drafted node — pending editorial review._
Connections
mometasone inhaled is a side effect of
Sources
- Inhaled indacaterol/glycopyrronium/mometasone furoate fixed-dose combination in moderate-to-severe asthma. (2022) pubmed
- Dose bridging data for mometasone furoate in once-daily fixed-dose inhaled combinations of mometasone furoate/indacaterol and mometasone furoate/ indacaterol/glycopyrronium in patients with asthma. (2021) pubmed
- Mometasone furoate: an inhaled glucocorticoid for the management of asthma in adults and children. (2009) pubmed
- A Practical Guide to Implementing SMART in Asthma Management. (2022) pubmed
- Inhaled mometasone furoate: a review of its use in adults and adolescents with persistent asthma. (2001) pubmed
- Mometasone or Tiotropium in Mild Asthma with a Low Sputum Eosinophil Level. (2019) pubmed
- Mometasone, Inhalation. (2006) pubmed
- Inhaled mometasone furoate: A review of its use in persistent asthma in adults and adolescents. (2006) pubmed
- Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial. (2016) pubmed
- A review of the pharmacology and pharmacokinetics of inhaled fluticasone propionate and mometasone furoate. (2001) pubmed